within Pharmacolibrary.Drugs.ATC.J;

model J01DD04
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 1.3333333333333333e-05,
    adminDuration  = 600,
    adminMass      = 1000 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.007,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.0056,
    k12             = 0.62,
    k21             = 0.62
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>J01DD04</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Ceftriaxone is a third-generation cephalosporin antibiotic with broad-spectrum activity against both gram-positive and gram-negative bacteria. It is widely used for the treatment of infections such as pneumonia, meningitis, gonorrhea, and sepsis. Ceftriaxone is approved for clinical use worldwide and is often administered intravenously or intramuscularly in both hospital and outpatient settings.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult subjects after single intravenous administration.</p><h4>References</h4><ol><li><p>Richards, DM, et al., &amp; Avery, GS (1984). Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use. <i>Drugs</i> 27(6) 469–527. DOI:<a href=&quot;https://doi.org/10.2165/00003495-198427060-00001&quot;>10.2165/00003495-198427060-00001</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6329638/&quot;>https://pubmed.ncbi.nlm.nih.gov/6329638</a></p></li><li><p>Cetin, G, et al., &amp; Uney, K (2021). Effect of ketoprofen and tolfenamic acid on intravenous pharmacokinetics of ceftriaxone in sheep. <i>Journal of veterinary pharmacology and therapeutics</i> 44(6) 945–951. DOI:<a href=&quot;https://doi.org/10.1111/jvp.13001&quot;>10.1111/jvp.13001</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/34312894/&quot;>https://pubmed.ncbi.nlm.nih.gov/34312894</a></p></li><li><p>Buragohain, R, et al., &amp; Mandal, TK (2021). Pharmacokinetics and Efficacy of Ceftriaxone in Staphylococcal Mastitis in Crossbred Cows Following Single Intravenous Administration. <i>Current drug metabolism</i> 22(5) 383–390. DOI:<a href=&quot;https://doi.org/10.2174/1389200222666210210113641&quot;>10.2174/1389200222666210210113641</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33568029/&quot;>https://pubmed.ncbi.nlm.nih.gov/33568029</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end J01DD04;
